Pharmacologically induced N‐methyl‐D‐aspartate receptor hypofunction impairs goal‐directed food seeking in rats. Issue 4 (20th September 2021)

• Record Type: Journal Article
• Authors: Ozawa, Takaaki; Itokazu, Tatsumi; Ichitani, Yukio; Yamada, Kazuo
• Is Part Of: Neuropsychopharmacology reports. Volume 41:Issue 4(2021)
• Page Start: 526
• Page End: 531
• Publication Date: 2021-09-20
• Subjects: devaluation -- MK‐801 -- NMDA receptor -- rats -- schizophrenia; Neuropsychopharmacology -- Periodicals; 615.78
• DOI: 10.1002/npr2.12209
• Languages: English
• ISSNs: 2574-173X

Abstract

Abstract: Aim: Acute N‐methyl‐D‐aspartate (NMDA) receptor antagonism is an important pharmacological animal model of schizophrenia. In previous studies, schizophrenia patients show impaired goal‐directed behavior in an outcome‐specific devaluation procedure. In this study, we investigated whether the rat model of the NMDA receptor blockade also showed altered goal‐directed behavior in a satiety‐induced outcome devaluation paradigm. Methods: In experiments 1 and 2, we aimed to establish the satiety‐induced outcome devaluation test using sucrose and lipid rewards in operant conditioning and free consumption paradigms. In experiment 3, we tested the effect of MK‐801 (0.1 mg/kg, i.p.) on outcome‐specific devaluation. Results: Experiments 1 and 2 demonstrated that 1‐h ad libitum food consumption is sufficient to induce outcome‐specific devaluation in both lever‐press and free consumption tests in rats. Experiment 3 showed that the administration of MK‐801 impaired satiety‐induced devaluation in the lever‐press test but not in the subsequent free consumption test. Conclusions: Our results suggest that acute pharmacological NMDA receptor antagonism in rats is a useful animal model for impaired goal‐directed behavior in schizophrenia. Abstract : Effects of NMDA receptor blockade on goal‐directed behavior in a satiety‐induced outcome devaluation paradigm. Acute MK‐801 administration impaired satiety‐induced devaluation but not in free food consumption. Acute pharmacological NMDA receptor antagonism in rats is a useful animal model for impaired goal‐directed behavior in schizophrenia.